Nothing Special   »   [go: up one dir, main page]

KR20030049190A - Storage method of eukaryote cell on transfer - Google Patents

Storage method of eukaryote cell on transfer Download PDF

Info

Publication number
KR20030049190A
KR20030049190A KR1020010079335A KR20010079335A KR20030049190A KR 20030049190 A KR20030049190 A KR 20030049190A KR 1020010079335 A KR1020010079335 A KR 1020010079335A KR 20010079335 A KR20010079335 A KR 20010079335A KR 20030049190 A KR20030049190 A KR 20030049190A
Authority
KR
South Korea
Prior art keywords
cells
carbon dioxide
cell
eukaryotic cells
eukaryotic
Prior art date
Application number
KR1020010079335A
Other languages
Korean (ko)
Inventor
박경찬
조현주
Original Assignee
주식회사 웰스킨
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 웰스킨 filed Critical 주식회사 웰스킨
Priority to KR1020010079335A priority Critical patent/KR20030049190A/en
Publication of KR20030049190A publication Critical patent/KR20030049190A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02Preservation of living parts
    • A01N1/0205Chemical aspects
    • A01N1/021Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Environmental Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

PURPOSE: A method of storing eukaryotic cells in a vessel filled with carbon dioxide is provided, thereby safely transferring and maintaining eukaryotic cells and tissues, improving the survival rate thereof and inhibiting cell differentiation. CONSTITUTION: Eukaryotic cells are stored in a vessel filled with 5 to 30% by volume of carbon dioxide while transferring the same. The eukaryotic cells are cells cultured in human beings and animals, cancer cells, immortal cell lines, artificial tissue, transgenic cells or tissue.

Description

이송시 진핵세포의 보관방법{STORAGE METHOD OF EUKARYOTE CELL ON TRANSFER}STORAGE METHOD OF EUKARYOTE CELL ON TRANSFER}

[발명이 속하는 기술분야][TECHNICAL FIELD OF THE INVENTION]

본 발명은 이송시 진핵세포의 보관방법에 관한 것으로, 보다 상세하게는 5 내지 30 부피%의 탄산가스가 충진된 상태에서 진핵세포를 보관함으로써 진핵세포의 활성을 유지시킨 채 이송시킬 수 있는 방법에 관한 것이다.The present invention relates to a method for storing eukaryotic cells during transport, and more particularly, to a method capable of transporting eukaryotic cells by maintaining eukaryotic cells in a state in which 5 to 30% by volume of carbon dioxide is filled. It is about.

[종래기술][Private Technology]

세포 또는 조직은 단백질의 생산, 조직 이식, 독성검사, 시약테스트 및 분자생물학적 연구에 필수적으로 사용되고 있으며, 세포를 장기간 보관할 수 있는 장치 및 방법들이 개발되었다. 통상적으로 사용되는 세포보관방법은 액체질소의 극저온성(-196 ℃)을 이용한 냉동보존방법으로, 그 외의 세포의 보관 및 배양을 위한 다양한 방법들이 개발되어 세포주은행(ATCC, KCTC)등에서 널리 사용되고 있다.Cells or tissues are essential for protein production, tissue transplantation, toxicity testing, reagent testing, and molecular biological research. Devices and methods have been developed that allow long-term storage of cells. Commonly used cell storage method is cryopreservation method using cryogenic (-196 ℃) of liquid nitrogen, various methods for the storage and culture of other cells have been developed and widely used in cell line banks (ATCC, KCTC), etc. .

이에 반하여, 세포를 분양하여 장기간 수송하는 경우 대부분 냉동보존된 세포를 드라이아이스에 보관하여 이동시킨다. 드라이아이스는 영하 20도의 조건을 제공하므로, 안정한 세포이송방법이 되지 못한다. 드라이아이스를 이용하여 세포를 이송한 경우 세포의 생리적 활성이 감소될 수 있으며, 장시간에 걸쳐 이송하는 경우 드라이아이스가 녹아 최상의 활성을 유지시키기 어렵다.On the contrary, in the case of prolonged transport of cells, most cryopreserved cells are stored in dry ice and moved. Dry ice does not provide a stable cell transfer method because it provides a temperature of minus 20 degrees. When the cells are transported using dry ice, the physiological activity of the cells may be reduced, and when transported for a long time, the dry ice melts and it is difficult to maintain the best activity.

원핵세포의 또다른 보관 및 이송방법으로는 동결건조방법이 있으며, 살아있는 혐기성 원핵세포인 경우 세포의 종류에 따라 적절한 농도의 탄산가스가 충진된 용기에 보관하는 방법을 사용하고 있다. 그러나 조직 등의 진핵세포는 원핵세포에 비하여 배양조건 및 이송조건이 까다로울 뿐만 아니라 세포활성을 유지시키기가 어렵다.Another method of storage and transfer of prokaryotic cells is lyophilization, and in the case of live anaerobic prokaryotic cells, a method of storing them in a container filled with a carbon dioxide gas at an appropriate concentration according to the type of cells is used. However, eukaryotic cells such as tissues are more difficult to culture and transport than prokaryotic cells, and are difficult to maintain cellular activity.

본 발명은 진핵세포 및 조직을 용이하게 이송할 수 있는 진핵세포 보관방법을 제공하는 것을 목적으로 한다.An object of the present invention is to provide a eukaryotic cell storage method that can easily transport eukaryotic cells and tissues.

또한 본 발명은 진핵세포 및 조직을 안전하게 이송할 수 있는 진핵세포 보관방법을 제공하는 것을 목적으로 한다.It is another object of the present invention to provide a eukaryotic cell storage method capable of safely transporting eukaryotic cells and tissues.

또한 본 발명은 진핵세포 및 조직을 안전하게 유지시킬 수 있는 방법을 제공하는 것을 목적으로 한다.It is another object of the present invention to provide a method for safely maintaining eukaryotic cells and tissues.

도 1은 탄산가스 포치에 보관한 각질형성세포 및 대기중에 방치한 각질형성세포를 관찰한 현미경사진이고,1 is a micrograph observing keratinocytes stored in the carbon dioxide porch and keratinocytes left in the air,

도 2는 탄산가스 포치에 보관한 각질형성세포 및 대기중에 방치한 각질형성세포의 세포생존율을 측정한 그래프이고,Figure 2 is a graph measuring the cell survival rate of keratinocytes stored in the carbon dioxide porch and keratinocytes left in the air,

도 3은 탄산가스 포치에 보관한 섬유모세포 및 대기중에 방치한 섬유모세포를 관찰한 현미경사진이고,3 is a micrograph of the fibroblasts stored in the carbon dioxide porch and the fibroblasts left in the air.

도 4는 탄산가스 포치에 보관한 섬유모세포 및 대기중에 방치한 섬유모세포의 세포생존율을 측정한 그래프이다.Figure 4 is a graph measuring the cell viability of the fibroblasts stored in the carbon dioxide porch and the fibroblasts left in the atmosphere.

상기 목적을 달성하기 위하여 본 발명은 진핵세포의 이송시 5 내지 30 부피%의 탄산가스가 충진된 용기에 진핵세포를 보관하는 진핵세포 보관방법을 제공한다.In order to achieve the above object, the present invention provides a eukaryotic cell storage method for storing eukaryotic cells in a container filled with carbon dioxide gas of 5 to 30% by volume during transfer of eukaryotic cells.

이하 본 발명을 상세하게 설명한다.Hereinafter, the present invention will be described in detail.

본 발명자들은 탄산가스가 진핵세포의 보관 및 이송에 안전성을 부여할 수 있는 조건을 형성함을 확인하여 본 발명을 완성하였다. 일반적으로 생체내의 탄산가스 농도는 약 5% 내외로 유지된다. 따라서, 이러한 탄산가스 농도를 진핵세포의 보관 및 이송에 적용시켜 진핵세포의 활성을 유지시키고자 하였다.The present inventors have completed the present invention by confirming that carbon dioxide gas forms a condition that can impart safety to the storage and transport of eukaryotic cells. In general, the concentration of carbon dioxide in vivo is maintained at about 5%. Therefore, this carbon dioxide concentration was applied to the storage and transport of eukaryotic cells to maintain the activity of eukaryotic cells.

본 발명의 진핵세포 보관방법은 5 내지 30 부피%의 탄산가스가 충진된 용기내에 진핵세포를 두는 것이다. 본 발명에서 언급하는 진핵세포는 사람 및 동물에서 배양된 세포, 암세포, 불멸화 세포주, 인공조직, 형질전환주 또는 조직을 포함한다.Eukaryotic cell storage method of the present invention is to place the eukaryotic cells in a container filled with 5 to 30% by volume carbon dioxide gas. Eukaryotic cells referred to in the present invention include cells, cancer cells, immortalized cell lines, artificial tissues, transformants or tissues cultured in humans and animals.

탄산가스의 충진량이 5 부피% 미만인 경우 진핵세포의 생리활성을 유지시키기 어려우며, 30 부피%를 초과할 경우 과도하게 높은 탄산가스 농도로 인하여 세포가 죽는 문제점이 발생할 수 있다. 가장 바람직한 탄산가스의 충진량은 5-10 부피 %이다.If the filling amount of the carbon dioxide gas is less than 5% by volume it is difficult to maintain the physiological activity of the eukaryotic cells, when the excess of 30% by volume may cause a problem that the cells die due to excessively high carbon dioxide concentration. The most preferable filling amount of carbon dioxide is 5-10% by volume.

본 발명의 용기는 탄산가스의 농도를 유지할 수 있는 종류의 재질을 사용할수 있으며, 혐기성 균 배양 또는 이송을 위하여 사용하는 용기, 탄산가스 포치(pouch), 백(bag) 등을 사용할 수 있다.The container of the present invention may use a kind of material capable of maintaining the concentration of carbon dioxide, and may be a container, a carbon dioxide pouch, a bag, or the like, used for culturing or transporting anaerobic bacteria.

백에 탄산가스를 충진하기 위하여 탄산가스백에 5 내지 30 부피%의 탄산가스를 방출할 수 있는 탄산가스 방출용액을 넣거나, 탄산가스를 충진한 다음 30도 내외의 온도에서 보관한다. 탄산가스가 충진된 용기는 약 5일간 세포 및 조직을 보관할 수 있는 탄산가스 농도로 유지된다.In order to fill the bag with carbon dioxide gas, a carbon dioxide gas-releasing solution capable of releasing 5 to 30% by volume of carbon dioxide gas is charged or filled with carbon dioxide gas and then stored at a temperature of about 30 degrees. A container filled with carbon dioxide is maintained at a concentration of carbon dioxide that can hold cells and tissue for about five days.

또한 탄산가스가 충진된 용기는 세포보관중 용기내 탄산가스의 농도를 일정하게 유지시킬 수 있는 장치를 추가로 포함하는 것이 바람직하다. 상기 장치는 탄산가스의 농도를 감지하여 탄산가스를 생성시키거나, 시간당 일정속도로 탄산가스를 배출시키는 것이다. 이러한 장치는 5일 이상의 장기간 보관 및 이송에 필요하다.In addition, the container filled with the carbon dioxide gas preferably further includes a device capable of maintaining a constant concentration of the carbon dioxide gas in the container during cell storage. The device detects the concentration of carbon dioxide gas to produce carbon dioxide gas or discharge carbon dioxide gas at a constant rate per hour. Such devices are necessary for long-term storage and transport of more than 5 days.

상기한 진핵세포 보관방법에 사용되는 세포는 보관 및 이송 중의 세포증식을 고려하여 30 내지 70 %의 컨플루언시로 배양한 것을 용기에 보관하는 것이 좋으나, 세포의 배양정도는 이에 한정되지 않는다. 바람직하게는 50 %의 컨플루언시로 배양한 세포를 배양액에 침지하여 용기내로 보관시키는 것이다. 배양액은 통상적인 세포 배양배지가 바람직하며, 세포의 특성 및 종류에 따라 적절한 배지를 사용하는 것이 더욱 바람직하다.Cells used in the above eukaryotic cell storage method is preferably stored in a container cultured with 30 to 70% confluence in consideration of cell proliferation during storage and transport, but the degree of culture of the cells is not limited thereto. Preferably, cells cultured with 50% confluency are immersed in the culture solution and stored in a container. The culture medium is preferably a conventional cell culture medium, it is more preferable to use a suitable medium according to the characteristics and types of cells.

본 발명의 진핵세포 보관방법은 진핵세포의 활성을 유지시켜 생존율을 향상시키고, 세포분화를 저해한다.The eukaryotic cell storage method of the present invention maintains the activity of eukaryotic cells to improve survival rate and inhibit cell differentiation.

이하 본 발명의 실시예를 기재한다. 하기 실시예는 본 발명을 예시하기 위한 것일 뿐 본 발명이 하기 실시예에 한정되는 것은 아니다.Hereinafter, examples of the present invention will be described. The following examples are only for illustrating the present invention and the present invention is not limited to the following examples.

이산화탄소가 5 부피% 내지 10 부피%가 충진된 탄산가스 포치를 BBL사의 Campy pouch system(BBL, 260656)로 구입하여 사용하였다.Carbon dioxide gas porch filled with 5% by volume to 10% by volume of carbon dioxide was purchased from BBL's Campy Pouch system (BBL, 260656) and used.

실시예 1: 각질형성 세포의 보관Example 1 Storage of Keratinocytes

각질형성세포(Keratinocyte)를 KGM(Clonetics, CC-3101)배지에서 70 퍼센트의 컨플루언시를 가질 때까지 배양하였다. 배양한 각질형성세포가 배양되고 있는 배양용기를 탄산가스 포치에 넣어 밀봉 후 상온에 방치하였다.Keratinocytes were cultured in KGM (Clonetics, CC-3101) medium until they had 70 percent confluency. The culture vessel in which the cultured keratinocytes were cultured was placed in a carbon dioxide gas porch and left to stand at room temperature after sealing.

대조예Control

대조군으로 각질형성세포를 상온에 방치하였다.Keratinocytes were left at room temperature as a control.

실시예 2: 세포 보관에 따른 세포활성 측정Example 2: Measurement of Cell Activity According to Cell Storage

실시예 1 및 대조예의 각질형성 세포는 상온에서 방치하면서 시간에 따른 세포활성을 측정하였다.The keratinocytes of Example 1 and control were measured for cell activity over time while standing at room temperature.

1일, 2일, 3일, 6일에 각질형성세포는 현미경(inverted microscope)상에서 세포형태변화를 관찰하였고, MTT 분석으로 세포의 사멸정도를 측정하였다.At 1, 2, 3, and 6 days, keratinocytes were observed for morphological changes on an inverted microscope, and the degree of cell death was measured by MTT analysis.

(1) 현미경 관찰(1) microscopic observation

현미경 관찰결과, 대조군의 각질형성세포는 상온 방치 2-3일 후부터 세포가 조기 분화되는 양상을 나타내었으며, 탄산가스가 충진된 포치에 방치한 실험군은 방치 6일이 지날때까지 정상적인 형태를 보였다.As a result of microscopic observation, keratinocytes of the control group showed early differentiation of cells after 2-3 days of room temperature, and the experimental group left in a porch filled with carbon dioxide showed normal morphology until 6 days of standing.

도 1은 상온 3일 후 각질형성세포의 세포활성을 관찰한 현미경사진으로, a는 탄산가스 포치에 보관된 각질형성세포이고, b는 대기중에 방치한 각질 형성세포이다. 탄산가스 포치에 보관한 경우 대기중 방치한 경우에 비하여 세포수가 많았으며, 세포의 활성도 역시 우수한 것으로 관찰되었다. 또한 대기중 방치한 대조군은 세포가 분화된 특성을 나타내었다.Figure 1 is a micrograph observing the cell activity of keratinocytes after 3 days at room temperature, a is keratinocytes stored in the carbon dioxide porch, b is keratinocytes left in the atmosphere. When stored in a carbon dioxide porch, the number of cells was larger than that in the air, and the activity of the cells was also excellent. In addition, the control group left in the air showed a differentiation characteristics.

(2) MTT 분석(2) MTT analysis

실시예 1 및 대조군의 각질형성세포를 96웰 플레이트에 두고, MTT 용액 0.5 ㎎/㎖를 포함한 배지에서 4 시간 배양하였다. 200 ㎕ 디메틸설폭사이드(DMSO) 용액을 웰에 넣고 용해시킨 후, ELISA 판독기를 사용하여 540 ㎚에서 흡광도를 측정하였다. 각 용액의 흡광도를 환산하여 세포생존율을 측정하였고, 표 1 및 도 2에 나타내었다.The keratinocytes of Example 1 and the control were placed in 96-well plates and incubated for 4 hours in a medium containing 0.5 mg / ml of MTT solution. 200 μl dimethylsulfoxide (DMSO) solution was added to the wells and dissolved, and the absorbance was measured at 540 nm using an ELISA reader. The cell viability was measured by converting the absorbance of each solution, shown in Table 1 and FIG.

D0D0 D1D1 D2D2 D3D3 D6D6 대조군(%)Control group (%) 100+4.6100 + 4.6 115+1.9115 + 1.9 108+3.9108 + 3.9 113+4.1113 + 4.1 122+5.6122 + 5.6 실시예 1(%)Example 1 (%) 100+4.6100 + 4.6 108+4.1108 + 4.1 106+4.1106 + 4.1 109+7.2109 + 7.2 131+13.3131 + 13.3

탄산가스 포치를 사용한 실시예 1의 세포생존율이 대조군에 비하여 우수하였다.Cell viability of Example 1 using the carbon dioxide porch was superior to the control.

따라서 탄산가스 포치를 이용한 세포보관은 세포생존율을 향상시키고 세포의 분화를 저해하여 이송시 세포보관의 최적방법이다.Therefore, cell storage using carbonic acid gas porch is an optimal method of cell storage during transport by improving cell viability and inhibiting the differentiation of cells.

실시예 3: 섬유모세포Example 3: Fibroblasts

섬유모세포는 DMEM(Gibco, 12800-0580)배지에서 약 90 %의 컨플루언시를 가질 때까지 배양하였다. 섬유모세포를 탄산가스 포치(Campy pouch system, BBL, 260656)에 넣어 실험군을 준비하고, 대조군은 대기중에 둔후 상온에 방치하였다.대조군과 실험군은 방치 시간에 따라 세포형태 및 생존율을 측정하였다.Fibroblasts were cultured in DMEM (Gibco, 12800-0580) media until they had about 90% confluency. The fibroblasts were placed in a carbon dioxide gas porch (Campy pouch system, BBL, 260656) to prepare an experimental group, and the control group was left in the air and left at room temperature.

(1) 현미경 관찰(1) microscopic observation

현미경으로 섬유모세포의 세포형태를 관찰하였다.The cell morphology of fibroblasts was observed under a microscope.

도 3은 섬유모세포의 세포활성을 관찰한 현미경사진으로, a는 탄산가스 포치에 보관된 섬유모세포이고, b는 대기중에 방치한 섬유모세포이다. 탄산가스 포치에 보관 세포는 세포수가 유지되는 반면, 대기중에 방치한 섬유모세포는 대부분이 죽은 것을 관찰되었다. 실험군과 대조군의 세포는 형태학적 변화가 관찰되지 않았다.Figure 3 is a micrograph observing the cell activity of the fibroblasts, a is the fibroblasts stored in the carbon dioxide porch, b is the fibroblasts left in the atmosphere. Cells kept in the carbon dioxide porch retained cell numbers, while most of the fibroblasts left in the air were dead. Morphological changes were not observed in the cells of the experimental and control groups.

(2) MTT 분석(2) MTT analysis

실험군과 대조군의 세포생존율을 MTT 분석으로 측정하였다. 표 2 및 도 4에 기재된 바와 같이, 실험군과 대조군의 세포생존율이 큰 차이를 나타내었다. 즉 실험군의 생존율이 대조군에 비하여 현저히 우수하였다.Cell viability of the experimental group and the control group was measured by MTT analysis. As shown in Table 2 and Figure 4, the cell survival rate of the experimental group and the control group showed a big difference. That is, the survival rate of the experimental group was significantly superior to the control group.

D0D0 D1D1 D2D2 D3D3 D6D6 대조군(%)Control group (%) 100+18.1100 + 18.1 123+4.3123 + 4.3 43+2.643 + 2.6 15+0.615 + 0.6 16+1.516 + 1.5 실험군(%)Experimental group (%) 100+18.1100 + 18.1 109+4.2109 + 4.2 99+9.599 + 9.5 94+1.994 + 1.9 118+2.0118 + 2.0

따라서, 탄산가스를 이용한 세포보관방법은 섬유모세포를 최적의 상태로 이송할 수 있는 방법이다.Therefore, the cell storage method using carbon dioxide gas is a method that can transport the fibroblasts in an optimal state.

실시예 4: 조직의 보존Example 4: Preservation of Tissue

조직은 일반적으로 4 ℃에서 보존하나 실제적으로 조직의 상태를 확인할 수 있는 표준화된 방법은 없다. 탄산가스 보관법의 효용성을 확인하기 위하여 세포배양을 위하여 얻은 피부조직을 탄산가스백에 보관후 세포배양을 시행하였다. 24 시간 및 48 시간 배양 후 MTT 분석으로 생존세포수를 측정하였고, 그 결과는 표 3에 나타내었다.Tissues are generally preserved at 4 ° C, but there is no standardized way to actually determine the state of tissues. In order to confirm the effectiveness of the carbon dioxide storage method, the skin tissues obtained for cell culture were stored in a carbon dioxide gas bag and then cell cultured. Viable cell number was measured by MTT assay after 24 hours and 48 hours incubation, the results are shown in Table 3.

D0D0 D1D1 D2D2 대조군(%)Control group (%) 100+7.5100 + 7.5 52.2+15.952.2 + 15.9 9.3+2.49.3 + 2.4 실험군(%)Experimental group (%) 100+7.5100 + 7.5 78.9+8.478.9 + 8.4 27.2+5.527.2 + 5.5

실험결과 상온에 방치한 조직과 비교하여 배양된 세포의 수가 월등하게 많아 탄산가스백에 조직을 보관함으로써 조직의 활성을 대기중 방치에 비하여 향상시킬 수 있음을 알 수 있었다.As a result of the experiment, the number of cultured cells was much higher than that of the tissues stored at room temperature, and the tissue activity was improved by storing the tissues in a carbon dioxide gas bag.

본 발명은 탄산가스를 이용하여 진핵세포를 보관함으로써 진핵세포의 활성을 유지시킬 수 있을 뿐만 아니라 진핵세포의 상태를 보관 초기의 상태로 유지시킨다.The present invention not only maintains eukaryotic activity by storing eukaryotic cells using carbon dioxide, but also maintains eukaryotic cells in their initial state.

Claims (2)

진핵세포의 이송시 5 내지 30 부피%의 탄산가스가 충진된 용기에 진핵세포를 보관하는 진핵세포 보관방법.Eukaryotic cell storage method for storing the eukaryotic cells in a container filled with 5 to 30% by volume of carbon dioxide during the transport of eukaryotic cells. 제 1항에 있어서, 상기 진핵세포는 사람 및 동물에서 배양된 세포, 암세포, 불멸화 세포주, 인공조직, 형질전환주 또는 조직인 진핵세포 보관방법.The method of claim 1, wherein the eukaryotic cells are cells, cancer cells, immortalized cell lines, artificial tissues, transformants or tissues cultured in humans and animals.
KR1020010079335A 2001-12-14 2001-12-14 Storage method of eukaryote cell on transfer KR20030049190A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020010079335A KR20030049190A (en) 2001-12-14 2001-12-14 Storage method of eukaryote cell on transfer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020010079335A KR20030049190A (en) 2001-12-14 2001-12-14 Storage method of eukaryote cell on transfer

Publications (1)

Publication Number Publication Date
KR20030049190A true KR20030049190A (en) 2003-06-25

Family

ID=29575012

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020010079335A KR20030049190A (en) 2001-12-14 2001-12-14 Storage method of eukaryote cell on transfer

Country Status (1)

Country Link
KR (1) KR20030049190A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61124379A (en) * 1984-11-22 1986-06-12 Agency Of Ind Science & Technol Culture of animal cell
EP0256730A2 (en) * 1986-08-08 1988-02-24 Distillers Mg Limited Container for the preservation and transportation of severed limbs or other body parts
JPH06277050A (en) * 1993-03-26 1994-10-04 Kanegafuchi Chem Ind Co Ltd Immobilization material for animal cell and culture method
WO2000054584A1 (en) * 1999-03-18 2000-09-21 Bio-Tech Imaging, Inc. Method of preparing cryogenically preserved adherent cell containing plate for tissue culture applications

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61124379A (en) * 1984-11-22 1986-06-12 Agency Of Ind Science & Technol Culture of animal cell
EP0256730A2 (en) * 1986-08-08 1988-02-24 Distillers Mg Limited Container for the preservation and transportation of severed limbs or other body parts
JPH06277050A (en) * 1993-03-26 1994-10-04 Kanegafuchi Chem Ind Co Ltd Immobilization material for animal cell and culture method
WO2000054584A1 (en) * 1999-03-18 2000-09-21 Bio-Tech Imaging, Inc. Method of preparing cryogenically preserved adherent cell containing plate for tissue culture applications

Similar Documents

Publication Publication Date Title
Jang et al. Cryopreservation and its clinical applications
CN109090100A (en) A kind of mesenchymal stem cell cryopreserving liquid and preparation method thereof and application method
McCarey et al. Improved corneal storage
CA2084648C (en) Cryopreservation of cultured epithelial sheets
KR100328742B1 (en) Method and package design for cryopreservation and storage of cultured tisse equivalents
EP0399647B1 (en) Method of revitalizing cells prior to cryopreservation
US5635344A (en) Shipping medium for organ-derived cells
Wang et al. Cryopreservation of tissue-engineered dermal replacement in Me2SO: Toxicity study and effects of concentration and cooling rates on cell viability
US6743575B2 (en) Compositions and methods for the preservation of living tissues
CA2074162A1 (en) Composition to improve survival of biological materials
CA2474968A1 (en) Cryopreservation medium for primate embryo stem cells and cryopreservation method
JP6580028B2 (en) Cryopreservation of viable human skin substitute
CN108040460A (en) The method of freezen protective tumor infiltrating lymphocyte
CA2336661A1 (en) Inclusion of apoptotic regulators in solutions for cell storage at low temperature
WO2005014792A2 (en) Preservation of biomaterials with transported preservation agents
WO2007001744B1 (en) Methods and compositions for enhancing vascular access
US20070059826A1 (en) Method to Preserve Cells
AU2011351883B2 (en) Method of freezing cells
JP2024098028A (en) Compositions for transportation and/or cryopreservation of cells and/or tissues
Bissoyi et al. Effects of non-toxic cryoprotective agents on the viability of cord blood derived MNCs
US5670308A (en) Cryoprotective aqueous solutions useful for the preservation of in vitro cultured epithelial sheets
KR101954120B1 (en) Composition for cryopreservation of stem cells having improved cryopreservation effect and method using the same
CN110234750A (en) Cell freezes composition and cryopreservation methods
KR20030049190A (en) Storage method of eukaryote cell on transfer
EP3035798A1 (en) Boron added cell cryopreservation medium

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application